Emerging Markets can benefit from rapid growth and potentially higher returns, which can beat their developed market counterparts. These markets also tend to benefit from high population growth and technology developments offering the potential for competitive returns over the long term. Managed by our specialist investment partner, Northcape Capital, the Fund uses a unique, disciplined and proven investment process, focused on deep fundamental stock and sector research. Combined with a rigorous portfolio construction approach and risk discipline the Fund is focused on building real wealth over the long-term, by limiting downside risks, whilst capturing steady growth. Northcape Capital has been managing global emerging markets equities for institutional investors for over 15 years and investors can now get exclusive access to this strategy via the Warakirri Global Emerging Markets Fund.
Actively managed and diversified portfolio of typically 20 – 40 high quality emerging market companies diversified by geography, industry and market capitalisation.
A long-term investment approach based on the belief that superior investment returns rely on fundamental investment research, good judgement and experience.
The ability for the portfolio manager to call on the research from typically 400 research meetings a year visiting companies in their home market.
Benchmark | MSCI Emerging Markets Total Return Index in AUD |
Stock Range | 20 – 40 |
Individual Stock Weight | 0-10% |
Inception Date | 22 July 2020 |
Fund Size | $117m |
Distribution Frequency | Semi-Annual |
Currency | Unhedged |
APIR Code | WRA4779AU |
ARSN | 642 392 863 |
1 month % | 3 months % | FYTD % | 1 year % | 2 years % pa | 3 years % pa | Since inception (22/07/2020) % pa | |
---|---|---|---|---|---|---|---|
Fund | -1.44 | -1.92 | -1.92 | +9.56 | +10.50 | -0.25 | +2.95 |
Benchmark | +4.33 | +4.66 | +4.66 | +17.27 | +14.23 | +1.76 | +5.28 |
Relative Return | -5.77 | -6.58 | -6.58 | -7.71 | -3.73 | -2.01 | -2.33 |
Past performance is not a reliable indicator of future performance. The return of capital is not guaranteed.
For since inception performance of the Global Emerging Markets strategy by the underlying manager, Northcape Capital visit here.
Current Unit Price |
Month-end Unit Price |
|
---|---|---|
Application | $1.1268 | $1.1147 |
Redemption | $1.12 | $1.1081 |
Distribution Rate | Reinvestment Price | |
---|---|---|
30 June 2024 | $0.00 | N/A |
31 December 2023 | $0.00232003 | $1.0855 |
30 June 2023 | $0.00 | N/A |
31 December 2022 | $0.00 | N/A |
30 June 2022 | $0.00 | N/A |
31 December 2021 | $0.00 | N/A |
30 June 2021 | $0.01575703 | $1.1054 |
31 December 2020 | $0.00 | N/A |
Company Name | Sector | Country | Weighting |
---|---|---|---|
Taiwan Semiconductor Manufacturing Co., Ltd. | Information Technology | Taiwan | 8.8% |
Hdfc Bank | Financials | India | 7.1% |
Maruti Suzuki | Consumer Discretionary | India | 6.4% |
Samsung Electronics Co., Ltd. | Information Technology | South Korea | 6.1% |
Tata Consultancy | Information Technology | India | 5.8% |
Bank Central Asia | Financials | Indonesia | 5.8% |
Femsa Unit Ubd | Consumer Staples | Mexico | 4.8% |
Sk Hynix | Information Technology | South Korea | 4.6% |
America Movil Sab De Cv | Communication Services | Mexico | 4.3% |
Grupo Aerop Pacifico B | Consumer Staples | Poland | 3.9% |
57.6% |
Portfolio holdings are subject to change
31% | Information Technology | |
19% | Financials | |
14% | Consumer Discretionary | |
12% | Industrials | |
10% | Consumer Staples | |
8% | Communication Services | |
2% | Healthcare | |
1% | Utilities | |
1% | Real Estate | |
2% | Cash | |
23% | India | |
18% | Mexico | |
16% | South Korea | |
15% | Taiwan | |
7% | Indonesia | |
6% | China/HK | |
3% | Brazil | |
1% | Malaysia | |
9% | Other | |
2% | Cash | |
Platform | |
---|---|
BT Panorama | Mason Stevens |
BT Wrap | Netwealth |
FNZ | North |
HUB24 | Powerwrap |
Macquarie Vision | Praemium |
Macquarie Wrap |
What is the Warakirri Global Emerging Markets Fund (“Fund”)?
The Fund is an actively managed investment fund that provides investors with access to a portfolio of hand-picked companies in Emerging Markets diversified by geography, industry, and size of market capitalisation. The Fund aims to achieve long-term capital growth through a disciplined and proven investment process.
Why invest in Emerging Markets?
Emerging Markets are those whose economies are transitioning from developing to developed status and typically hold greater growth potential compared to the developed markets (such as Australian and global equity markets). Listen to this podcast to learn more about the investment opportunity in emerging markets.
What is the investment strategy of the Fund?
The Fund utilises an active management approach. The Fund’s investment manager seeks to invest in no more than 40 high quality businesses invested over an average time frame of three or more years based on their growth potential, diversified by country, industry and size within the emerging markets universe.
What benchmark is the Fund measured against?
The Fund’s benchmark is the MSCI Emerging Markets Total Return Index in AUD. This index tracks mid-cap and large-cap stocks across 24 emerging markets countries.
Who is the investment manager?
Northcape Capital is an international boutique fund manager fully owned by its staff. Northcape specialise in managing concentrated high-quality equity portfolios and has delivered significant value-added returns since their establishment in 2004, facilitating growth in funds under management to more than A$10 billion.
Important Legal Information
The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned WRA4779AU November 2023) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.
The rating issued May 2024 is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2022 Lonsec. All rights reserved.
Past performance is not necessarily indicative of future performance.
This website is maintained by Warakirri Asset Management Limited (ABN 33 057 529 370) (Australian Financial Services Licence Holder No. 246782) and provides general product information only and does not constitute financial advice as it does not take into account an individual’s personal circumstances and is not an offer or solicitation to enter into an agreement. Investors should not rely on the information on this website and should refer to the Fund’s Product Disclosure Statement (PDS), Additional Information Booklet and TMD, and seek independent advice from their financial adviser. A PDS and TMD for the Fund is available at on this website or by calling 1300 927 254. The PDS and TMD should be considered before making an investment decision. Investments entail risks, the value of investments can go down as well as up and investors should be aware they might not get back the full value invested. Portfolio holdings are subject to change.
This website is intended for Australian investors only. Information on this website may not be suitable for all investors and clients. By using this website you agree to and acknowledge the Terms of Use. Click here to view Terms of Use.